Insomnia Therapeutics Market Growth Is Accelerating As Industry Transformation Continues
Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.
Insomnia Therapeutics Market Forecast: What Market Value Is Expected By 2030?
The insomnia therapeutics market has experienced notable growth in recent years, expanding from $3.2 billion in 2025 to $3.38 billion in 2026, reflecting a compound annual growth rate (CAGR) of 5.7%. This upward trajectory in the historic period has been driven by a higher incidence of sleep disorders, a surge in stress and lifestyle-induced insomnia, broader utilization of prescription sleep medications, enhanced availability through retail pharmacies, and increasing public consciousness regarding the importance of sleep health.
Over the coming years, robust expansion is anticipated for the insomnia therapeutics market, with projections indicating that by 2030, it will reach $4.19 billion, representing a compound annual growth rate of 5.5%. Several key factors are fueling this growth during the forecast period, including the advancement of digital sleep therapeutics, a heightened inclination toward non-pharmacological interventions, an expanding elderly demographic, greater utilization of wearable sleep monitoring devices, and the broadening accessibility of telehealth services for managing insomnia. Additionally, prominent trends shaping the market encompass an increased uptake of cognitive behavioral therapy for insomnia, a shift toward non-habit-forming sleep aids, the expanding application of orexin receptor antagonists, the growth of in-home sleep therapy options, and the more frequent incorporation of sleep tracking into treatment protocols.
Download A Free Sample Report For Comprehensive Market Insights:
Insomnia Therapeutics Market Demand Drivers: What Is Fueling Industry Growth?
The rising incidence of stress and evolving lifestyles is anticipated to drive future expansion in the insomnia therapeutics market. Stress levels and lifestyle modifications involve the psychological and behavioral adjustments in everyday routines and obligations that lead to emotional tension and irregular sleep patterns. These heightened stress levels and lifestyle shifts are fueled by persistent digital connectivity, which blurs the line between work and personal life and diminishes opportunities for genuine mental relaxation. Insomnia therapeutics provides essential, evidence-based therapeutic options that aid in reestablishing consistent sleep cycles, alleviating sleep-associated anxiety, and fostering psychological well-being in the face of contemporary pressures. For example, in May 2024, data from the American Psychiatric Association (APA), a U.S.-based psychiatric organization, indicated that the proportion of American adults experiencing increased anxiety grew from 32% in 2022 to 37% in 2023, and further to 43% in 2024. Consequently, the growing prevalence of stress and lifestyle changes is fueling the expansion of the insomnia therapeutics market.
Insomnia Therapeutics Market Segment Analysis: What Are The Major Market Categories?
The insomnia therapeutics market covered in this report is segmented –
1) By Treatment Type: Drugs, Medical Devices
2) By Formulation: Tablets, Capsules, Liquid Solutions, Patches
3) By Route Of Administration: Oral, Intravenous, Transdermal, Other Routes Of Administration
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Clinics, Wellness Centers
Subsegments:
1) By Drugs: Benzodiazepines, Nonbenzodiazepines, Antidepressants, Orexin Antagonists, Melatonin Antagonists, Other Drugs
2) By Medical Devices: Cognitive Behavioral Therapy Devices (CBT-I Devices), Polysomnography Devices, Sleep Tracking Devices, Neurostimulation Devices, Light Therapy Devices
Insomnia Therapeutics Market Innovation Trends: Which Developments Are Transforming The Industry?
Major players within the insomnia therapeutics sector are prioritizing the development of cutting-edge treatments, including dual orexin receptor antagonists (DORAs), which aim to deliver targeted relief while minimizing adverse effects and enhancing safety. This class of drugs functions by inhibiting both orexin-1 and orexin-2 receptors in the brain, effectively suppressing the wakefulness signal and facilitating sleep, making it a common approach for managing insomnia. A notable example occurred in June 2023, when Idorsia Pharmaceuticals Ltd., a pharmaceutical firm headquartered in Switzerland, introduced QUVIVIQ (daridorexant), a pioneering dual orexin receptor antagonist (DORA) designed to address chronic insomnia disorder. This therapy is engineered to decrease nighttime wakefulness without disrupting the body’s natural sleep patterns, thereby improving how quickly patients fall asleep, how long they stay asleep, and their daytime alertness. The approval of this medication represents a notable milestone in insomnia care, offering a distinct mode of action that sets it apart from conventional sedative-hypnotics and fulfilling the demand for sustainable, non-addictive treatment solutions.
Insomnia Therapeutics Market Leading Companies Driving Competitive Growth
Major companies operating in the insomnia therapeutics market are Pfizer Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Eli Lilly and Company, Merck KGaA, Eisai Co. Ltd., Sumitomo Pharma Co. Ltd., Astellas Pharma Inc., Acadia Pharmaceuticals Inc., Vanda Pharmaceuticals Inc., Idorsia Ltd., Minerva Neurosciences, Neurim Pharmaceuticals Ltd., Big Health, Cerêve Inc., Innovative Neurological Devices, Neurovalens, Electromedical Products International Inc., Pear Therapeutics, ResMed Inc.
Access The Complete Insomnia Therapeutics Market Report:
Insomnia Therapeutics Market Regional Analysis And Leading Geography
North America was the largest region in the insomnia therapeutics market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insomnia therapeutics market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
